CN108409540B - 一种治疗骨关节炎的化合物及其制备与应用 - Google Patents
一种治疗骨关节炎的化合物及其制备与应用 Download PDFInfo
- Publication number
- CN108409540B CN108409540B CN201810191958.1A CN201810191958A CN108409540B CN 108409540 B CN108409540 B CN 108409540B CN 201810191958 A CN201810191958 A CN 201810191958A CN 108409540 B CN108409540 B CN 108409540B
- Authority
- CN
- China
- Prior art keywords
- methanol
- chloroform
- column chromatography
- extract
- volume ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 19
- 150000001875 compounds Chemical class 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000010828 elution Methods 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003208 petroleum Substances 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 12
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 12
- 238000004440 column chromatography Methods 0.000 claims abstract description 10
- 241001166791 Carex purpurifera Species 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 8
- 239000002024 ethyl acetate extract Substances 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000000499 gel Substances 0.000 claims abstract description 6
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 7
- 238000011068 loading method Methods 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 3
- 241000700159 Rattus Species 0.000 description 6
- 102000003777 Interleukin-1 beta Human genes 0.000 description 4
- 108090000193 Interleukin-1 beta Proteins 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical group OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 2
- 241001448535 Reineckea carnea Species 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 102000001707 3',5'-Cyclic-AMP Phosphodiesterases Human genes 0.000 description 1
- 108010054479 3',5'-Cyclic-AMP Phosphodiesterases Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000646197 Carex nigra Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002587 anti-hemolytic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/28—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing seven carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810191958.1A CN108409540B (zh) | 2018-03-08 | 2018-03-08 | 一种治疗骨关节炎的化合物及其制备与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810191958.1A CN108409540B (zh) | 2018-03-08 | 2018-03-08 | 一种治疗骨关节炎的化合物及其制备与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108409540A CN108409540A (zh) | 2018-08-17 |
CN108409540B true CN108409540B (zh) | 2020-12-08 |
Family
ID=63130586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810191958.1A Active CN108409540B (zh) | 2018-03-08 | 2018-03-08 | 一种治疗骨关节炎的化合物及其制备与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108409540B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010059058A (ja) * | 2008-09-01 | 2010-03-18 | Kowa Co | 鎮痛・抗炎症剤含有外用剤 |
CN106138629A (zh) * | 2016-07-29 | 2016-11-23 | 刘泽智 | 一种治疗肩周炎的药物及制备方法 |
CN106349021A (zh) * | 2016-08-25 | 2017-01-25 | 赣南医学院第附属医院 | 一种吉祥草中的化合物及其制备与应用 |
-
2018
- 2018-03-08 CN CN201810191958.1A patent/CN108409540B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010059058A (ja) * | 2008-09-01 | 2010-03-18 | Kowa Co | 鎮痛・抗炎症剤含有外用剤 |
CN106138629A (zh) * | 2016-07-29 | 2016-11-23 | 刘泽智 | 一种治疗肩周炎的药物及制备方法 |
CN106349021A (zh) * | 2016-08-25 | 2017-01-25 | 赣南医学院第附属医院 | 一种吉祥草中的化合物及其制备与应用 |
Non-Patent Citations (3)
Title |
---|
Anti-inflammatory and Chondroprotective Activity of (+)-α-Pinene:Structural and Enantiomeric Selectivity;Ana T. Rufino,等;《Journal of Natural Products》;20140123;第77卷;摘要 * |
吉祥草化学成分的分离与鉴定;陈苓丽,等;《吉祥草化学成分的分离与鉴定》;20111130;第28卷(第11期);全文 * |
吉祥草挥发油化学成分的研究;刘海,等;《分析测试学报》;20080531;第27卷(第5期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN108409540A (zh) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113150048B (zh) | 青钱柳的提取物及其抗类风湿性关节炎应用 | |
CN105218489A (zh) | 一种新的杂萜化合物及其制备方法和医药用途 | |
CN114524825A (zh) | 牛尾蒿内酯a-t及其药物组合物和其制备方法与应用 | |
CN101574398B (zh) | 啤酒花提取物及其制备方法与应用 | |
CN108409540B (zh) | 一种治疗骨关节炎的化合物及其制备与应用 | |
CN103191143B (zh) | 一种强心苷化合物的用途 | |
CN114903926B (zh) | 珊瑚树叶中Vibsane型总二萜及其制备方法和应用 | |
CN112250655B (zh) | 两种新的环状二苯基庚烷类化合物及其制备方法和用途 | |
CN109091602B (zh) | 韭菜子有效成分、提取方法及其在制备保护肝损伤药物方面的应用 | |
CN106377523B (zh) | 一种天然活性药物及其制备与应用 | |
CN107936001B (zh) | 芹菜素-8-C-β-D-木糖苷及其制备方法和应用 | |
CN112939912A (zh) | 一种毛菊苣提取物莴苣苦素的制备方法及其应用 | |
CN107213176B (zh) | 一种八仙花叶提取物及其药物组合物、制备方法和应用 | |
CN106176873B (zh) | 一种荠菜总生物碱提取物及其制备方法和应用 | |
CN111892634A (zh) | 一种源于生等的糖苷化合物、提取方法及其应用 | |
CN106349021B (zh) | 一种吉祥草中的化合物及其制备与应用 | |
CN104398532B (zh) | 一种强心苷化合物的用途 | |
CN104053447B (zh) | 天南星提取物及其用于创伤‑愈合作用的用途 | |
CN117658777A (zh) | 艾里莫酚型倍半萜化合物及其制备方法与应用 | |
CN112778255B (zh) | 鹅不食草内酯l及提取方法及其用途 | |
CN112898358B (zh) | 一个从牛蒡叶中提取的具有抗炎活性的新化合物nby-4及其制备方法与应用 | |
CN114762703B (zh) | 超高压白花丹参浓缩口服液及其制备方法 | |
CN104324043A (zh) | 一种强心苷化合物的用途 | |
CN115772178B (zh) | 一种生物碱化合物或其药学上可接受的盐及其制备和应用 | |
CN113999245B (zh) | 具有抗胰腺癌活性的天然化合物及其分离方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240617 Address after: 264000 No. 4, No. 1-3, Zhiwei North 1st Street, Zhifu District, Yantai City, Shandong Province Patentee after: Li Guosheng Country or region after: China Patentee after: Li Haining Address before: Jining second people's Hospital, No.65, Hongxing East Road, Rencheng District, Jining City, Shandong Province 272000 Patentee before: Tang Xujun Country or region before: China |